• Actively engage with stakeholders, including patients, healthcare providers, regulators, scientific experts, technology providers and policy makers to understand and address their concerns surrounding patient centric sampling and analysis.

​​

• Act as a platform for collaborative activities associated with the development and implementation of patient centric sampling and analysis technologies for the provision of high quality information for decision making by stakeholders.

​​

• Act as a focal point for enquiries from stakeholders on patient centric sampling and related technologies.

​​

• Provide a framework for maintaining the highest standards of ethics, data integrity, scientific quality, compliance and transparency in the interest group’s activities.

​​

• Is free to join and is open to all that are interested in furthering its remit and no bias is shown to any particular organization or technology.

 

• Company proprietary intellectual property will not be shared, unless publicly available.

​​

• Any promotional activities associated with the marketing and pricing of patient centric blood sampling and analysis technologies by the interest group members is outside the scope of this interest group.